Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 268

1.

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.

Nout RA, Smit VT, Putter H, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, Mens JW, Slot A, Kroese MC, van Bunningen BN, Ansink AC, van Putten WL, Creutzberg CL; PORTEC Study Group.

Lancet. 2010 Mar 6;375(9717):816-23. doi: 10.1016/S0140-6736(09)62163-2.

PMID:
20206777
2.

Adjuvant radiotherapy for stage I endometrial cancer.

Kong A, Johnson N, Kitchener HC, Lawrie TA.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD003916. doi: 10.1002/14651858.CD003916.pub4. Review.

3.

External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study.

Sorbe B, Horvath G, Andersson H, Boman K, Lundgren C, Pettersson B.

Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1249-55. doi: 10.1016/j.ijrobp.2011.04.014. Epub 2011 Jun 14.

PMID:
21676554
4.

Adjuvant radiotherapy for stage I endometrial cancer.

Kong A, Johnson N, Kitchener HC, Lawrie TA.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD003916. doi: 10.1002/14651858.CD003916.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;(4):CD003916.

PMID:
22419290
5.

Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.

Alektiar KM, Venkatraman E, Chi DS, Barakat RR.

Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):111-7.

PMID:
15850910
6.

Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis.

Kong A, Johnson N, Kitchener HC, Lawrie TA.

J Natl Cancer Inst. 2012 Nov 7;104(21):1625-34. doi: 10.1093/jnci/djs374. Epub 2012 Sep 6. Review.

PMID:
22962693
7.
8.

External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma: a prospective, randomized study--quality-of-life analysis.

Sorbe BG, Horvath G, Andersson H, Boman K, Lundgren C, Pettersson B.

Int J Gynecol Cancer. 2012 Sep;22(7):1281-8. doi: 10.1097/IGC.0b013e3182643ba0.

PMID:
22864336
9.

Adjuvant Chemotherapy and Vaginal Vault Brachytherapy With or Without Pelvic Radiotherapy for Stage 1 Papillary Serous or Clear Cell Endometrial Cancer.

Tétreault-Laflamme A, Nguyen-Huynh TV, Carrier JF, Samouëlian V, Sauthier P, Beauchemin MC, Barkati M.

Int J Gynecol Cancer. 2016 Feb;26(2):301-6. doi: 10.1097/IGC.0000000000000611.

PMID:
26745699
10.

Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma.

Creutzberg CL, Nout RA, Lybeert ML, Wárlám-Rodenhuis CC, Jobsen JJ, Mens JW, Lutgens LC, Pras E, van de Poll-Franse LV, van Putten WL; PORTEC Study Group.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e631-8. doi: 10.1016/j.ijrobp.2011.04.013. Epub 2011 Jun 2.

11.

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.

Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, De Winter KA, Lutgens LC, van den Bergh AC, van de Steen-Banasik E, Beerman H, van Lent M.

Lancet. 2000 Apr 22;355(9213):1404-11.

PMID:
10791524
12.

The role of vaginal cuff brachytherapy in endometrial cancer.

Harkenrider MM, Block AM, Siddiqui ZA, Small W Jr.

Gynecol Oncol. 2015 Feb;136(2):365-72. doi: 10.1016/j.ygyno.2014.12.036. Epub 2014 Dec 31. Review.

PMID:
25555710
13.

The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.

Barney BM, Petersen IA, Mariani A, Dowdy SC, Bakkum-Gamez JN, Haddock MG.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):109-15. doi: 10.1016/j.ijrobp.2012.03.011. Epub 2012 Apr 28.

PMID:
22543202
14.

Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma.

Horowitz NS, Peters WA 3rd, Smith MR, Drescher CW, Atwood M, Mate TP.

Obstet Gynecol. 2002 Feb;99(2):235-40.

PMID:
11814503
15.

Pelvic control following external beam radiation for surgical stage I endometrial adenocarcinoma.

Rush S, Gal D, Potters L, Bosworth J, Lovecchio J.

Int J Radiat Oncol Biol Phys. 1995 Nov 1;33(4):851-4.

PMID:
7591893
16.

Perineal template interstitial brachytherapy salvage for recurrent endometrial adenocarcinoma metastatic to the vagina.

Nag S, Martínez-Monge R, Copeland LJ, Vacarello L, Lewandowski GS.

Gynecol Oncol. 1997 Jul;66(1):16-9.

PMID:
9234914
17.

Stage II adenocarcinoma of the endometrium: adjuvant radiotherapy and recurrence patterns.

Cozad SC.

Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):205-12. doi: 10.1016/j.ijrobp.2007.09.022. Epub 2007 Dec 31.

PMID:
18164851
18.

Adenocarcinoma of the endometrium treated with combined irradiation and surgery: study of 437 patients.

Touboul E, Belkacémi Y, Buffat L, Deniaud-Alexandre E, Lefranc JP, Lhuillier P, Uzan S, Jannet D, Uzan M, Antoine M, Huart J, Ganansia V, Milliez J, Blondon J, Housset M, Schlienger M.

Int J Radiat Oncol Biol Phys. 2001 May 1;50(1):81-97.

PMID:
11316550
19.

American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy.

Small W Jr, Erickson B, Kwakwa F.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1502-7. Epub 2005 Aug 18.

PMID:
16109462
20.

Recurrences and toxicity after adjuvant vaginal brachytherapy in Stage I-II endometrial cancer: A monoinstitutional experience.

Perrucci E, Lancellotta V, Bini V, Zucchetti C, Mariucci C, Montesi G, Saccia S, Palumbo I, Aristei C.

Brachytherapy. 2016 Mar-Apr;15(2):177-84. doi: 10.1016/j.brachy.2015.10.010. Epub 2015 Dec 22.

PMID:
26727332

Supplemental Content

Support Center